SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-020379
Filing Date
2020-08-05
Accepted
2020-08-05 16:13:08
Documents
4
Period of Report
2020-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea124947-8k_hoththerap.htm 8-K 23330
2 SUBLICENSE AGREEMENT BY AND BETWEEN THE COMPANY AND ISOPRENE PHARMACEUTICS, INC. ea124947ex10-1_hoth.htm EX-10.1 260142
3 PRESS RELEASE DATED JULY 31, 2020 ea124947ex99-1_hoth.htm EX-99.1 9956
4 GRAPHIC image_001.jpg GRAPHIC 3867
  Complete submission text file 0001213900-20-020379.txt   300032
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 201077423
SIC: 2834 Pharmaceutical Preparations